Enhancing Selectivity and Inhibitory Effects of Chemotherapy Drugs Against Myelogenous Leukemia Cells with
Oils, Volatile
/ pharmacology
Lippia
/ chemistry
Acyclic Monoterpenes
/ pharmacology
Humans
Cell Line, Tumor
Antineoplastic Agents
/ pharmacology
Cytarabine
/ pharmacology
Leukemia, Myeloid, Acute
/ drug therapy
Clofarabine
/ pharmacology
Apoptosis
/ drug effects
Drug Synergism
Oxidative Stress
/ drug effects
Cell Proliferation
/ drug effects
Lippia alba
acute myelogenous leukemia
chemotherapy
citral
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
16 Aug 2024
16 Aug 2024
Historique:
received:
30
07
2024
revised:
13
08
2024
accepted:
14
08
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
Acute myelogenous leukemia (AML) is one of the most lethal cancers, lacking a definitive curative therapy due to essential constraints related to the toxicity and efficacy of conventional treatments. This study explores the co-adjuvant potential of
Identifiants
pubmed: 39201605
pii: ijms25168920
doi: 10.3390/ijms25168920
pii:
doi:
Substances chimiques
Oils, Volatile
0
citral
T7EU0O9VPP
Acyclic Monoterpenes
0
Antineoplastic Agents
0
Cytarabine
04079A1RDZ
Clofarabine
762RDY0Y2H
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministry of Science, Technology, and Innovation, the Ministry of Education, the Ministry of In-dustry, Commerce and Tourism, and ICETEX, Programme Ecosistema Científico - Colombia Científica, from the Francisco José de Caldas Fund
ID : RC-FP44842-212-2018